Company intelligence / Profile preview

JM10 Partners

New York, New York, United States

Ownership: Private
Development stage: Other

Overview

JM10 Partners is a private equity and venture capital firm primarily focused on the cannabis and life sciences sectors. The firm is widely recognized for its role as a founding investor in Cronos Group, a leading global cannabinoid company. JM10 specializes in identifying and scaling high-growth opportunities within the legal cannabis market, ranging from medical research to consumer-facing brands. The firm provides strategic capital and operational expertise to help its portfolio companies navigate complex regulatory landscapes and achieve institutional scale. Based in New York, JM10 Partners has been a key player in the professionalization of cannabis-related investments.

Industry: Investors

Beyond the preview

Go deeper on JM10 Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on JM10 Partners.

Explore the full profile